Intelligent model for diagnosing and treating insomnia

Study on an Intelligent Model for the Diagnosis and Treatment of Insomnia Disorder

This study is trying to create better ways to diagnose and treat insomnia by following 16,000 people over two years to see how the condition affects their lives and what helps improve it.

Quick facts

• Study type: Observational
• Enrollment: 16000 (estimated)
• Ages: 18 Years to 75 Years
• Sex: All
• Sponsor: Xuanwu Hospital, Beijing (Academic / other)
• Locations: 5 sites (Beijing and 4 other locations)
• Trial ID: NCT06375447 on ClinicalTrials.gov

What this trial studies

This study aims to create a large multicenter cohort of 16,000 individuals diagnosed with insomnia disorder, followed over two years. It focuses on understanding the natural progression of insomnia, identifying contributing factors, and assessing its impacts on various aspects of life. The research will develop advanced screening methods and treatment strategies using real-time assessment technology, ultimately leading to a systematic framework for diagnosing and treating insomnia across different age groups.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 to 75 who experience insomnia and can independently complete assessment scales.

Not a fit: Patients with current or a history of comorbid Axis I psychiatric disorders may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses and effective treatments for patients suffering from insomnia.

How similar studies have performed: Other studies have shown promise in using intelligent models for diagnosis and treatment, but this approach is innovative in its scale and methodology.

Eligibility criteria

Inclusion Criteria:

1. A complaint of insomnia;
2. Age between 18 and 75;
3. Able to fill out the scale on their own;
4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit.

Exclusion Criteria:

1.A current or history of comorbid Axis I psychiatric disorders.

Where this trial is running

Beijing and 4 other locations

• Xuanwu Hospital, Capital Medical University — Beijing, China (Recruiting)
• Beijing Tiantan Hospital, Capital Medical University — Beijing, China (Recruiting)
• The First Bethune Hospital of Jilin University — Changchun, China (Not_yet_recruiting)
• West China Hospital, Sichuan University — Chengdu, China (Recruiting)
• The Second Affiliated Hospital of Soochow University — Suzhou, China (Not_yet_recruiting)

Study contacts

• Study coordinator: Huang Wang, MD

Conditions Insomnia; Intelligence Model; Prediction; Differential diagnosis and treatment; System